BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 30446998)

  • 1. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
    Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
    Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the downstream mediators of toll-like receptor 3-induced apoptosis in labial salivary glands in patients with Sjögren's syndrome.
    Horai Y; Nakamura H; Nakashima Y; Hayashi T; Kawakami A
    Mod Rheumatol; 2016; 26(1):99-104. PubMed ID: 25926385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.
    Ittah M; Miceli-Richard C; Eric Gottenberg J; Lavie F; Lazure T; Ba N; Sellam J; Lepajolec C; Mariette X
    Arthritis Res Ther; 2006; 8(2):R51. PubMed ID: 16507175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation.
    Rivière E; Pascaud J; Tchitchek N; Boudaoud S; Paoletti A; Ly B; Dupré A; Chen H; Thai A; Allaire N; Jagla B; Mingueneau M; Nocturne G; Mariette X
    Ann Rheum Dis; 2020 Nov; 79(11):1468-1477. PubMed ID: 32843324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
    Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.
    Apostolou E; Kapsogeorgou EK; Konsta OD; Giotakis I; Saridaki MI; Andreakos E; Tzioufas AG
    Clin Exp Immunol; 2016 Dec; 186(3):304-312. PubMed ID: 27613139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.
    Kyriakidis NC; Kapsogeorgou EK; Gourzi VC; Konsta OD; Baltatzis GE; Tzioufas AG
    Clin Exp Immunol; 2014 Dec; 178(3):548-60. PubMed ID: 25098814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of Toll-like receptor 7 and its correlation with clinical features in patients with primary Sjögren's syndrome.
    Yang H; Sun C; Wang X; Wang T; Xie C; Li Z
    Adv Rheumatol; 2024 Mar; 64(1):17. PubMed ID: 38439071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
    Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
    Front Immunol; 2019; 10():281. PubMed ID: 30846988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
    Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
    Yoshimura S; Nakamura H; Horai Y; Nakajima H; Shiraishi H; Hayashi T; Takahashi T; Kawakami A
    Mod Rheumatol; 2016; 26(3):384-90. PubMed ID: 26375433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Toll-like Receptor 7-Mediated Ro52 Antigen-Presenting Pathway in the Salivary Gland Epithelial Cells of Sjögren's Syndrome.
    Nishihata SY; Shimizu T; Umeda M; Furukawa K; Ohyama K; Kawakami A; Nakamura H
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line.
    Kawakami A; Nakashima K; Tamai M; Nakamura H; Iwanaga N; Fujikawa K; Aramaki T; Arima K; Iwamoto N; Ichinose K; Kamachi M; Ida H; Origuchi T; Eguchi K
    J Rheumatol; 2007 May; 34(5):1019-26. PubMed ID: 17407216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients.
    Nakamura H; Horai Y; Suzuki T; Okada A; Ichinose K; Yamasaki S; Koji T; Kawakami A
    Rheumatol Int; 2013 Feb; 33(2):441-50. PubMed ID: 22457005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome.
    Ainola M; Porola P; Takakubo Y; Przybyla B; Kouri VP; Tolvanen TA; Hänninen A; Nordström DC
    Clin Exp Immunol; 2018 Mar; 191(3):301-310. PubMed ID: 29105068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome.
    Kwok SK; Cho ML; Her YM; Oh HJ; Park MK; Lee SY; Woo YJ; Ju JH; Park KS; Kim HY; Park SH
    Arthritis Res Ther; 2012 Mar; 14(2):R64. PubMed ID: 22417709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.